• Citer

Single-arm study to assess comprehensive infusion guidance for the prevention and management of the infusion associated reactions (IARs) in relapsing-remitting multiple sclerosis (RRMS) patients treated with alemtuzumab (EMERALD)

par Vukusic, Sandra;Brassat, David;de Seze, Jerome;Izquierdo, Guillermo;Lysandropoulos, Andreas ;Moll, Wibe;Vanopdenbosch, Ludo;Arque, Maria Jesus;Kertous, Mehdi;Rufi, Pascal;Oreja-Guevara, Celia
Référence Multiple Sclerosis and Related Disorders, 29, page (7-14)
Publication Publié, 2019-04

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Single-arm study to assess comprehensive infusion guidance for the prevention and management of the infusion associated reactions (IARs) in relapsing-remitting multiple sclerosis (RRMS) patients treated with alemtuzumab (EMERALD)
Auteur:	Vukusic, Sandra; Brassat, David; de Seze, Jerome; Izquierdo, Guillermo; Lysandropoulos, Andreas; Moll, Wibe; Vanopdenbosch, Ludo; Arque, Maria Jesus; Kertous, Mehdi; Rufi, Pascal; Oreja-Guevara, Celia
Informations sur la publication:	Multiple Sclerosis and Related Disorders, 29, page (7-14)
Statut de publication:	Publié, 2019-04
Sujet CREF:	Neurologie
	Pharmacologie
Mots-clés:	Alemtuzumab
	Induction therapy
	Infusion-associated reaction (IAR)
	Methylprednisolone treatment
	Multiple sclerosis
	Rash
Note générale:	SCOPUS: ar.j
	DecretOANoAutActif
Langue:	Anglais
Identificateurs:	urn:issn:2211-0348
	info:doi/10.1016/j.msard.2019.01.019
	info:pii/S2211034819300197
	info:scp/85059864855